Rob Blum
- Co-authors
- Seena C. AisnerRobert B. LivingstonLawrence EinhornPatrick J. LoehrerDavid H. JohnsonKyungMann KimRodney J. HicksJohn F. Seymour
- Topics
- COVID-19 and healthcare impacts (2 papers)Medical Imaging Techniques and Applications (1 paper)Myasthenia Gravis and Thymoma (1 paper)
- Partner nations
- AustraliaUnited States
In The Last Decade
Rob Blum
6 papers receiving 333 citations
Peers
Comparison fields: 5 of 39
- Neurology 220
- Epidemiology 118
- Endocrinology, Diabetes and Metabolism 111
- Oncology 74
- Surgery 57
Countries citing papers authored by Rob Blum
This map shows the geographic impact of Rob Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Blum more than expected).
Fields of papers citing papers by Rob Blum
This network shows the impact of papers produced by Rob Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Blum. The network helps show where Rob Blum may publish in the future.
Co-authorship network of co-authors of Rob Blum
This figure shows the co-authorship network connecting the top 25 collaborators of Rob Blum. A scholar is included among the top collaborators of Rob Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Blum. Rob Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 56 | |
| 4 | 51 | |
| 5 | Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. | 7 |
| 6 | 218 |
About Rob Blum
Rob Blum is a scholar working on Oncology, Gender Studies and Hematology, having authored 6 papers that have together received 340 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (2 papers), Medical Imaging Techniques and Applications (1 paper) and Myasthenia Gravis and Thymoma (1 paper). The work is most often cited by research in Neurology (220 citations), Endocrinology, Diabetes and Metabolism (111 citations) and Hematology (40 citations). Rob Blum has collaborated with scholars based in Australia and United States. Frequent co-authors include Seena C. Aisner, Robert B. Livingston, Lawrence Einhorn, Patrick J. Loehrer, David H. Johnson, KyungMann Kim, Rodney J. Hicks, John F. Seymour, A. Patrikeos and H. Miles Prince. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.